VIM and cholangiocarcinoma: In our study, the functional experiments of the transwell assays demonstrated that DMY treatment suppressed the migration and invasion of CCA cell lines, which in line with EMT inhibition, indicated by decreased ZEB1 and its downstream protein of vimentin expression and upregulated E-cadherin expression in CCA cells treatment with DMY.